2021
DOI: 10.1055/s-0041-1726277
|View full text |Cite
|
Sign up to set email alerts
|

InspirerMundi—Remote Monitoring of Inhaled Medication Adherence through Objective Verification Based on Combined Image Processing Techniques

Abstract: Background The adherence to inhaled controller medications is of critical importance for achieving good clinical results in patients with chronic respiratory diseases. Self-management strategies can result in improved health outcomes and reduce unscheduled care and improve disease control. However, adherence assessment suffers from difficulties on attaining a high grade of trustworthiness given that patient self-reports of high-adherence rates are known to be unreliable. Objective Aiming to increase … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
13
0

Year Published

2021
2021
2025
2025

Publication Types

Select...
4
2
1

Relationship

4
3

Authors

Journals

citations
Cited by 10 publications
(13 citation statements)
references
References 46 publications
0
13
0
Order By: Relevance
“…Digital inhalers have the advantage of providing detailed information about medication taking which, when combined with artificial intelligence approaches, can revolutionize asthma and COPD care. For example, InspirerMundi allows remote monitoring of inhaler use via a machine learning approach that can assess medication self-administration [ 102 ]. If these artificial intelligence approaches can be applied to the “big data” captured by digital inhalers, there is potential that the data can help predict and/or mitigate future exacerbations.…”
Section: Methodsmentioning
confidence: 99%
“…Digital inhalers have the advantage of providing detailed information about medication taking which, when combined with artificial intelligence approaches, can revolutionize asthma and COPD care. For example, InspirerMundi allows remote monitoring of inhaler use via a machine learning approach that can assess medication self-administration [ 102 ]. If these artificial intelligence approaches can be applied to the “big data” captured by digital inhalers, there is potential that the data can help predict and/or mitigate future exacerbations.…”
Section: Methodsmentioning
confidence: 99%
“…When the patient confirms medication was taken, an initial screen with instructions on how to match the inhaler with the template is provided, but in the current version instead of an example figure, we use a short video demonstrating the task (patients can decide to inactivate these instructions whenever they want to accelerate the process). A feature to provide feedback on the identified number in the inhaler was already developed [16] allowing the user to correct the number, and it will be introduced in a future app version. Reasons for deciding not to take a medication can also be registered (eg, medication is empty, this dose is not needed, secondary effects).…”
Section: App Changes Based On Patient Use and Feedbackmentioning
confidence: 99%
“…New versions of the app should assess inhaler adherence more objectively by validating inhaler use through dose tracking. The medication detection tool is currently working with 13 inhaler devices containing numeric dose counters available on the Portuguese and Spanish markets [16]. To improve the generalizability of the app and its use in multicenter international studies, inhalers available in other countries will be added in future versions of the app.…”
Section: Xsl • Fomentioning
confidence: 99%
See 1 more Smart Citation
“…“Inspirers” can increase the sphere of positive influence by “coaching” an expanding network of users- “Warriors” (that, as they progress and keep good medication adherence, can become “Inspirers” themselves). The most innovative app technology is the medication detection tool based on advanced processing of inhaler images captured with the smartphone camera ( 12 ), which aims to offer an objective adherence measure that can be easily integrated into the lives of patients. It is believed that the app is suitable to be used by real-world patients as its development was grounded in previous research and cooperation with patients with asthma and physicians ( 13 ).…”
Section: Introductionmentioning
confidence: 99%